Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 71,215 |
|
|||||
| News | - | ||||||
| Day High | 16.225 | Low High |
|||||
| Day Low | 14.69 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Avalo Therapeutics Inc | AVTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.70 | 4.67% | 15.68 | 14:24:06 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 15.00 | 14.69 | 16.225 | 14.98 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 911 | 71,215 | US$ 15.30 | US$ 1,089,923 | - | 3.9501 - 1,130.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:24:10 | 3 | US$ 15.1901 | USD |
Avalo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.35M | 801.61k | - | 1.92M | -31.54M | -39.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Avalo Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.68 | 16.32 | 11.46 | 13.47 | 84,127 | 4.00 | 34.25% |
| 1 Month | 19.00 | 22.47 | 11.10 | 16.10 | 304,404 | -3.32 | -17.47% |
| 3 Months | 4.61 | 34.46 | 4.0101 | 19.35 | 716,683 | 11.07 | 240.13% |
| 6 Months | 25.92 | 34.46 | 3.9501 | 18.03 | 11,223,074 | -10.24 | -39.51% |
| 1 Year | 712.80 | 1,130.40 | 3.9501 | 33.37 | 23,586,247 | -697.12 | -97.80% |
| 3 Years | 688.80 | 1,711.20 | 3.9501 | 39.32 | 8,976,055 | -673.12 | -97.72% |
| 5 Years | 688.80 | 1,711.20 | 3.9501 | 39.32 | 8,976,055 | -673.12 | -97.72% |
Avalo Therapeutics Description
| Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. |
